ConductScience.org, home

Paper697346

In vitro studies with Sch 21420 and Sch 22591: activity in comparison with six other aminoglycosides and synergy with penicillin against enterococci.

Sanders CC and 2 others. Antimicrob Agents Chemother, 1978. Cited by 27 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. In vitro studies with Sch 21420 and Sch 22591: activity in comparison with six other aminoglycosides and synergy with penicillin against enterococci. Papers, record 697346. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/697346

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vitro studies with Sch 21420 and Sch 22591: activity in comparison with six other aminoglycosides and synergy with penicillin against enterococci.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1978
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
1.74
iCite
Revised in PubMed
2021-05-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sanders CCC C
2Sanders WE JrW E
3Goering RVR V

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
EnterobacteriaceaeMajor topic
GentamicinsMajor topic
Penicillin GMajor topic
SisomicinMajor topic
Aminoglycosides
Drug Synergism
Microbial Sensitivity Tests

Source PubMed

References6

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114,047,217NEISSERIA GONORRHOEAE. I. VIRULENCE GENETICALLY LINKED TO CLONAL VARIATION.J Bacteriol1963https://conductscience.org/library/papers/14047217PubMed
2242,509Synergy of penicillin-netilmicin combinations against enterococci including strains highly resistant to streptomycin or kanamycin.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/242509PubMed
3626,490Chemotherapeutic evaluation of 5-episisomicin (Sch 22591), a new semisynthetic aminoglycoside.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/626490PubMed
41,008,541Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/1008541PubMed
54,209,522Activity of BB-K8 (amikacin) against clinical isolates resistant to one or more aminoglycoside antibiotics.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4209522PubMed
64,468,277Mutamicins; biosynthetically created new sisomicin analogues.J Antibiot (Tokyo)1974https://conductscience.org/library/papers/4468277PubMed

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
8,851,618Temporal variation in nephrotoxicity of low doses of isepamicin in rats.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8851618PubMed
7,447,420Interpretive standards for disk susceptibility tests with Sch 21420 and amikacin.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7447420PubMed
7,447,410Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7447410PubMed
7,283,421In vitro studies with Win 42122-2: comparison with gentamicin, netilmicin, and amikacin.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/7283421PubMed
6,376,062Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.Drugs1984https://conductscience.org/library/papers/6376062PubMed
3,583,277Netilmicin: new approach to treating gonorrhoea.Genitourin Med1987https://conductscience.org/library/papers/3583277PubMed
2,689,137Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.Drugs1989https://conductscience.org/library/papers/2689137PubMed
742,870Comparison of 5-episisomicin (Sch 22591), gentamicin, sisomicin, and tobramycin in treatment of experimental Pseudomonas infections in mice.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/742870PubMed
518,078Comparative nephrotoxicity of SCH 21420 and amikacin in rats.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/518078PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/697346

GET https://conductscience.org/api/papers/v1/697346/authors